Agenus Inc (NAS:AGEN)
$ 3.905 -0.025 (-0.64%) Market Cap: 84.24 Mil Enterprise Value: 71.39 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 46/100

Q2 2019 Agenus Inc Earnings Call Transcript

Aug 08, 2019 / 12:30PM GMT
Release Date Price: $51.03 (+18.72%)
Operator

Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Agenus Second Quarter 2019 Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Dr. Jennifer Buell, Chief Operating Officer of Agenus. Dr. Buell. Please go ahead.

Jennifer Buell
Agenus Inc. - COO

Thank you, Brandon. Today's call is being webcast and will be available on our website with our accompanying slide material for replay.

Before we start, we'd like to remind you that this call will include forward-looking statements, including statements regarding our clinical development plans and time lines for date of release and partnership opportunities and time lines. These statements are subject to risks and uncertainties, and we refer you to our SEC filings for more details on these risks. As a reminder, this call is being recorded for audio broadcast.

I'm Jennifer Buell, Chief Operating Officer of Agenus. Today, we are delighted to provide an update on our business. Joining

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot